Longitudinal Assessment of Adults With Severe Asthma

NCT01976767 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 725

Last updated 2015-01-14

No results posted yet for this study

Summary

Cross-sectional study to characterize cohorts of subjects with asthma and healthy controls in terms of clinical features, physiological measurements and non-invasive measurement of biomarkers and develop phenotype handprints for adults with severe asthma

Conditions

Sponsors & Collaborators

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    lead OTHER

Principal Investigators

  • Peter Sterk, Dr. · Academic Medical Centre University of Amsterdam, The Netherlands

  • Ratko Djukanovic, Dr. · Southampton General Hospital, UK

  • Stephen Fowler, Dr. · Respiratory Research Group, Education and Research Centre, Wythenshawe Hospital, UK

  • Kian Fan Chung, Dr. · Imperial College London, UK

  • Barbro Dahlén, Dr. · Karolinska Institutet

  • Andrew Szczeklik, Dr. · Uniwersytet Jagielloński - Collegium Medicum, Kraków, Poland

  • Thomas Geiser, Dr. · Inselspital and University of Bern, Switzerland

  • Ildiko Horvath, Dr. · University School of Medicine, Budapest, Hundary

  • Pascal Chanez, Dr. · Université de la Méditerranee, Marseille, France

  • Jens Hohlfeld, Dr. · Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover

  • Thomas Sandström, Dr. · Department of Public Health and Clinical Medicine, Division of Medicine, Umea, Sweden

  • Dominick Shaw, Dr. · Nottingham City Hospita, Nottingham, UK

  • Per Sigvald Bakke, Dr. · Haukeland University Hospital, Bergen, Norway

  • Riccardo Polosa, Dr. · Policlinico Vittorio Emmanuele, Catania, Italy

  • Paolo Montuschi, Dr. · Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2013-10-31
Completion
2014-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01976767 on ClinicalTrials.gov